Once it is understood how new drugs are developed it becomes easier to understand why new drugs are priced the way they are.
Subscribe to:
Post Comments (Atom)
< + > It’s Time for “Actioning Information” to Move Past Interoperability’s Endless Data
The following is a guest article by E ffie Carlson, CEO at Watershed Health The Problem Is Not Only Data Availability, It’s What We Do Wi...
No comments:
Post a Comment